Related references
Note: Only part of the references are listed.Neutrophils in tissue injury and repair
Jing Wang
CELL AND TISSUE RESEARCH (2018)
Global emergence of the widespread Pseudomonas aeruginosa ST235 clone
P. Treepong et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Antibiotic treatment-induced secondary IgA deficiency enhances susceptibility to Pseudomonas aeruginosa pneumonia
Oliver H. Robak et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Risk factors for colonization and infection by Pseudomonas aeruginosa in patients hospitalized in intensive care units in France
S. Hoang et al.
PLOS ONE (2018)
Vaccine-induced Th17 cells are established as resident memory cells in the lung and promote local IgA responses
D. Christensen et al.
MUCOSAL IMMUNOLOGY (2017)
Design of live attenuated bacterial vaccines based on D-glutamate auxotrophy
Maria P. Cabral et al.
NATURE COMMUNICATIONS (2017)
Reconstruction of the metabolic network of Pseudomonas aeruginosa to interrogate virulence factor synthesis
Jennifer A. Bartell et al.
NATURE COMMUNICATIONS (2017)
A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients
Jordi Rello et al.
CRITICAL CARE (2017)
CD11b+ Mononuclear Cells Mitigate Hyperoxia-Induced Lung Injury in Neonatal Mice
Laurie C. Eldredge et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2016)
Impact of multidrug resistance on the pathogenicity of Pseudomonas aeruginosa: in vitro and in vivo studies
Silvia Gomez-Zorrilla et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
X-ray Irradiated Vaccine Confers protection against Pneumonia caused by Pseudomonas Aeruginosa
Yanyan Li et al.
SCIENTIFIC REPORTS (2016)
Phage Therapy: a Step Forward in the Treatment of Pseudomonas aeruginosa Infections
Diana P. Pires et al.
JOURNAL OF VIROLOGY (2015)
Vaccines for Pseudomonas aeruginosa: a long and winding road
Gregory P. Priebe et al.
EXPERT REVIEW OF VACCINES (2014)
Protective effect of intranasal immunization with Neospora caninum membrane antigens against murine neosporosis established through the gastrointestinal tract
Pedro Ferreirinha et al.
IMMUNOLOGY (2014)
A Phase I Clinical Study of a Live Attenuated Bordetella pertussis Vaccine-BPZE1; A Single Centre, Double-Blind, Placebo-Controlled, Dose-Escalating Study of BPZE1 Given Intranasally to Healthy Adult Male Volunteers
Rigmor Thorstensson et al.
PLOS ONE (2014)
The molecular mechanism of acute lung injury caused by Pseudomonas aeruginosa: from bacterial pathogenesis to host response
Teiji Sawa
JOURNAL OF INTENSIVE CARE (2014)
Biological Markers of Pseudomonas aeruginosa Epidemic High-Risk Clones
Xavier Mulet et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
A comparison of microbiology and demographics among patients with healthcare-associated, hospital-acquired, and ventilator-associated pneumonia: a retrospective analysis of 1184 patients from a large, international study
Andrew A. Quartin et al.
BMC INFECTIOUS DISEASES (2013)
Collaboration Between Macrophages and Vaccine-Induced CD4+ T Cells Confers Protection Against Lethal Pseudomonas aeruginosa Pneumonia During Neutropenia
Akinobu Kamei et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Pneumococcal Surface Protein A does not affect the immune responses to a combined diphtheria tetanus and pertussis vaccine in mice
Fernanda A. Lima et al.
VACCINE (2013)
The responses of γδ T-cells against acute Pseudomonas aeruginosa pulmonary infection in mice via interleukin-17
Jialin Liu et al.
PATHOGENS AND DISEASE (2013)
Pseudomonas aeruginosa: new insights into pathogenesis and host defenses
Shaan L. Gellatly et al.
PATHOGENS AND DISEASE (2013)
Th17-stimulating Protein Vaccines Confer Protection against Pseudomonas aeruginosa Pneumonia
Weihui Wu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Genetic Markers of Widespread Extensively Drug-Resistant Pseudomonas aeruginosa High-Risk Clones
Gabriel Cabot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Early production of IL-17 protects against acute pulmonary Pseudomonas aeruginosa infection in mice
Jialin Liu et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2011)
Wide Dispersion of ST175 Clone despite High Genetic Diversity of Carbapenem-Nonsusceptible Pseudomonas aeruginosa Clinical Strains in 16 Spanish Hospitals
Maria Garcia-Castillo et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study
Marie-Laurence Lambert et al.
LANCET INFECTIOUS DISEASES (2011)
Innate immune responses to Pseudomonas aeruginosa infection
Elise G. Lavoie et al.
MICROBES AND INFECTION (2011)
Risk factors and prognosis of post-operative pneumonia due to Pseudomonas aeruginosa following cardiac surgery
Nicolas Allou et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Pseudomonas aeruginosa: Host defence in lung diseases
Bryan J. Williams et al.
RESPIROLOGY (2010)
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Helen W. Boucher et al.
CLINICAL INFECTIOUS DISEASES (2009)
Inescapable Need for Neutrophils as Mediators of Cellular Innate Immunity to Acute Pseudomonas aeruginosa Pneumonia
Andrew Y. Koh et al.
INFECTION AND IMMUNITY (2009)
IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa
Gregory P. Priebe et al.
JOURNAL OF IMMUNOLOGY (2008)
Vaccination against Pseudomonas aeruginosa pneumonia in immunocompromised mice
Jennifer M. Scarff et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Mucoid Pseudomonas in cystic fibrosis
Bobbi Pritt et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2007)
A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients
Gerd Doering et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Population structure of Pseudomonas aeruginosa
Lutz Wiehlmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Defect in early lung defence against Pseudomonas aeruginosa in DBA/2 mice is associated with acute inflammatory lung injury and reduced bactericidal activity in naive macrophages
Kari R. Wilson et al.
MICROBIOLOGY-SGM (2007)
IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge
Shabaana A. Khader et al.
NATURE IMMUNOLOGY (2007)
IL-17 production is dominated by γδ T cells rather than CD4 T cells during Mycobacterium tuberculosis infection
Euan Lockhart et al.
JOURNAL OF IMMUNOLOGY (2006)
Live attenuated B-pertussis as a single-dose nasal vaccine against whooping cough
Nathalie Mielcarek et al.
PLOS PATHOGENS (2006)
Mucosal vaccines: the promise and the challenge
MR Neutra et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Risk factors for infections with multidrug-resistant Pseudomonas aeruginosa in patients with cancer
N Ohmagari et al.
CANCER (2005)
Mucosal immunity and vaccines
J Holmgren et al.
NATURE MEDICINE (2005)
Evaluation of genetic immunization adjuvants to improve the effectiveness of a human immunodeficiency virus type 2 (HIV-2) envelope DNA vaccine
CP Locher et al.
DNA AND CELL BIOLOGY (2004)
Genotypic and phenotypic analysis of type III secretion system in a cohort of Pseudomonas aeruginosa bacteremia isolates:: Evidence for a possible association between O serotypes and exo genes
P Berthelot et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Blood monocytes consist of two principal subsets with distinct migratory properties
F Geissmann et al.
IMMUNITY (2003)
Protection against fatal Pseudomonas aeruginosa pneumonia in mice after nasal immunization with a live, attenuated aroA deletion mutant
GP Priebe et al.
INFECTION AND IMMUNITY (2003)
Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread
M Allewelt et al.
INFECTION AND IMMUNITY (2000)
Share Paper
